3.12 USD
↘ 0.01 (0.16%)LIVE (AS OF 03:48 PM EST)
Shares of Ardelyx, Inc. (ARDX) are trading at $3.12. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. On the valuation side, ARDX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 12, 2026.
Open?$3.14
High?$3.15
Low?$3.06
Prev. Close?$3.12
Volume?1.8M
Avg. Volume?4.9M
VWAP?$3.08
Rel. Volume?0.36x
Bid / Ask
Bid?$3.09 × 18.3K
Ask?$3.10 × 5.0K
Spread?$0.01
Midpoint?$3.09
Valuation & Ratios
Market Cap?784.3M
Shares Out?251.4M
Float?243.2M
Float %?97.6%
P/E Ratio?N/A
P/B Ratio?4.78
EPS?-$0.22
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.
Employees
489
Market Cap
784.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2014-06-19
Address
34175 ARDENWOOD BLVD.
FREMONT, CA 94555
Phone: 510-745-7047
FREMONT, CA 94555
Phone: 510-745-7047
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▲ Bullish(+1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?12
Z-Score?3
Momentum?80
Short Sent.?54
Piotroski F-Score?2/9Weak
Altman Z-Score?-0.04Distress
Confidence?52%Low
Short InterestHigh
Short % of Float?12.01%High
Short Interest?29.2M
Days to Cover?7.5
Free Float243.2M
Avg Daily Volume3.9M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.45Strong
Quick Ratio?3.26Strong
Cash Ratio?0.36Low
Debt/Equity?1.54High
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score92/100
P/E?N/A▾
P/B?4.78FAIR▾
Peers100
S&P38
P/S?1.68CHEAP▾
Peers100
S&P75
P/FCF?N/A▾
EV/EBITDA?-30.0CHEAP▾
S&P97
EV/Sales?2.12CHEAP▾
Peers100
S&P73
Returns & Efficiency
ROE?-33.8%WEAK▾
S&P5
ROA?-9.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-15957000
Enterprise Value?$990.3M
Fundamentals ratios updated end of day